Inventor · disambiguated record
Laurent Gomez
Also filed as: GOMEZ LAURENT
29 granted patents·11 pending applications·77 citations·filing 2003–2025
96Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD11JANSSEN PHARMACEUTICA NV10DART NEUROSCIENCE LLC8IAMBIC THERAPEUTICS INC8ALLISON BRETT D2
Top patents by PatentIndex Score
40 records- 0194US9175010B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Nov 3, 2015·12 cites·17 claims
- 0289US9284335B2Substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines, pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines and/or [1,2,4]triazolo[1,5-c]pteridines for treatment of central nervous system diseases and disordersDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Mar 15, 2016·5 cites·26 claims
- 0388US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0487US9963435B2Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2016·Granted May 8, 2018·5 cites·10 claims
- 0587US9533996B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0686US9499562B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2013·Granted Nov 22, 2016·3 cites·27 claims
- 0785US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0884US10981916B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2017·Granted Apr 20, 2021·2 cites·20 claims
- 0984US10092575B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 9, 2018·3 cites·10 claims
- 1084US7935725B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 3, 2011·6 cites·16 claims
- 1184US7576092B2Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 18, 2009·6 cites·30 claims
- 1283US12145948B2Compounds and methods for modulating HER2IAMBIC THERAPEUTICS INC·Filed 2023·Granted Nov 19, 2024·1 cites·27 claims
- 1382US10738018B2Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2018·Granted Aug 11, 2020·2 cites·8 claims
- 1481US8367719B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 5, 2013·5 cites·21 claims
- 1579US10239882B2Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Mar 26, 2019·2 cites·20 claims
- 1679US8357684B2Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 22, 2013·5 cites·21 claims
- 1779US8344008B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 1, 2013·5 cites·4 claims
- 1878US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1977US2025136604A1Substituted pyrazolopyrimidinone compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 2077US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 2175US7939527B2Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 10, 2011·2 cites·37 claims
- 2273US8030321B2Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptorJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Oct 4, 2011·1 cites·14 claims
- 2372US11999738B2Substituted pyrazolopyrimidinone compounds as PDE2 inhibitorsDART NEUROSCIENCE LLC·Filed 2021·Granted Jun 4, 2024·0 cites·22 claims
- 2472US7842810B2Bicyclic pyrazole compounds as antibacterial agentsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Nov 30, 2010·1 cites·2 claims
- 2571US10376514B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 2671US7465808B2CCK-1 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 16, 2008·1 cites·3 claims
- 2771US2025276983A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2867US7037931B2CCK-1 receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted May 2, 2006·4 cites·48 claims
- 2967US2024132521A1Compounds and methods for modulating her2IAMBIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3062US10105367B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 3162US2021198218A1Compounds for therapeutic useDART NEUROSCIENCE LLC·Filed 2020·Application pending·0 cites
- 3261US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 3356US2024034731A1Aza-quinazoline compounds and methods of useIAMBIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3456US2024092761A1Quinazoline compounds and methods of useIAMBIC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3550US8242275B2Bicyclic pyrazole compounds as antibacterial agentsALLISON BRETT D·Filed 2010·Granted Aug 14, 2012·0 cites·28 claims
- 3647US8232391B2Bicyclic pyrazole compounds as antibacterial agentsALLISON BRETT D·Filed 2010·Granted Jul 31, 2012·0 cites·26 claims
- 3738US2025276984A1Solid state forms of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3836US2025235456A1Methods of use for aza-quinazoline compoundsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3936US2025345339A1Doses and regimens of her2 inhibitorsIAMBIC THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4028US8399465B2Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolaseBACANI GENESIS·Filed 2010·Granted Mar 19, 2013·0 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when Laurent Gomez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →